CWM
NVS icon

Compass Wealth Management’s Novartis NVS Stock Holding History

Compass Wealth Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.96M Sell
12,847
-100
-0.8% -$15.3K 0.49% 62
2025
Q4 		$1.79M Sell
12,947
-250
-2% -$32.7K 0.45% 63
2025
Q3 		$1.69M Sell
13,197
-125
-0.9% -$15.3K 0.38% 70
2025
Q2 		$1.61M Sell
13,322
-878
-6% -$99K 0.38% 71
2025
Q1 		$1.58M Sell
14,200
-800
-5% -$85.2K 0.4% 72
2024
Q4 		$1.46M Sell
15,000
-1,625
-10% -$173K 0.35% 75
2024
Q3 		$1.91M Sell
16,625
-950
-5% -$108K 0.45% 71
2024
Q2 		$1.87M Sell
17,575
-50
-0.3% -$5.02K 0.46% 71
2024
Q1 		$1.7M Sell
17,625
-660
-4% -$67.7K 0.43% 74
2023
Q4 		$1.85M Buy
18,285
+435
+2% +$42K 0.52% 65
2023
Q3 		$1.82M Sell
17,850
-350
-2% -$35.5K 0.57% 59
2023
Q2 		$1.84M Sell
18,200
-150
-0.8% -$15K 0.55% 60
2023
Q1 		$1.69M Hold
18,350
– – 0.54% 65
2022
Q4 		$1.66M Buy
+18,350
New +$1.55M 0.55% 63

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Compass Wealth Management's NVS Position: Q1 2026 in Review

Compass Wealth Management reduced its Novartis (NVS) stake by 0.77% in Q1 2026, selling an estimated $15.3K and leaving 12,847 shares worth $1.96M. The position accounts for 0.49% of the portfolio, ranked #62.

Compass Wealth Management first reported a position in NVS in Q4 2022 and has held it in 14 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Compass Wealth Management held 12,847 shares of Novartis worth $1.96M as of Q1 2026.
  • Compass Wealth Management sold 100 Novartis shares in Q1 2026, an estimated $15.3K.
  • Novartis made up 0.49% of Compass Wealth Management's portfolio in Q1 2026, its #62 holding.
  • Compass Wealth Management first reported a position in Novartis in Q4 2022 and has held it in 14 quarters since.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Compass Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.